Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Uterine Cervical Neoplasms 2Papillomavirus Infections 1

Interventions

Papillomavirus Vaccines 5human papillomavirus vaccine, L1 type 16, 18 2Vaccines 2Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 2halofantrine 1fludarabine 1VGX-3100 1Radiotherapy 1Polymerase Chain Reaction 1Interleukin-2 1Interferon alpha-2 1Cyclophosphamide 1Cidofovir 1Carboplatin 1Brachytherapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1 × Papillomavirus Infections × VGX-3100 × Clear all
NCT00685412 2017-09-13

Phase I of Human Papillomavirus (HPV) DNA Plasmid (VGX-3100) + Electroporation for CIN 2 or 3

Inovio Pharmaceuticals

Phase 1 Completed
18 enrolled
Gynecologic

Uterine Cervical Neoplasms, Papillomavirus Infections

Data powered by HemOnc (CC BY 4.0) Colophon âš¡